Robert Chess, Director at Twist Bioscience Corp (TWST), sold 18,417 shares at $110.89 ($2.0M) on 2026-08-07, disclosed to the SEC on 2026-08-11.
Scheduled sale ($2.0M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| TWST | SELL | 2025-02-11 | $312K | — | Filing → |
| TWST | SELL | 2025-01-10 | $250K | — | Filing → |
| TWST | SELL | 2024-12-30 | $326K | — | Filing → |